Disproportionality Analysis of Ivabradine in the US FDA Adverse Event Reporting System: A Real-World Study Across Overall and Indication-Specific Populations

American Journal of Cardiovascular Drugs · Published 2025-06-28 · DOI 10.1007/s40256-025-00734-z

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40256-025-00734-z

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles